Researcher

Dan Riskin

Also known as Daniel Riskin

Dan Riskin is a surgeon and healthcare AI researcher who applies artificial intelligence to clinical records and real-world evidence. During his UCLA surgical residency, he developed medical devices and received an Innovators Under 35 honor in 2005. He co-founded Health Fidelity, which launched REVEAL, a cloud-based clinical natural-language-processing service, in 2012. His research includes studies applying AI to migraine and asthma data in electronic health records. As of October 2026, he is Verantos' founder and CEO, a Clinical Professor of Surgery at Stanford University, and a member of HITAC through December 2026.

Now at
Verantos, Stanford University and Health Information Technology Advisory Committee
Works
34
Citations
929
h-index
11

Publication numbers from OpenAlex, as of 19 October 2026.

Timeline

  1. 2005

    Medical-device work at UCLA

    He develops medical devices for wound closure and early heart-attack intervention while training as a surgical resident at UCLA; Innovators Under 35 recognizes this work in 2005. His medical studies include Boston University and Tufts, and he enrolls in MIT Sloan's MBA program.

  2. 2012

    Health Fidelity launches REVEAL

    At Health Fidelity, he serves as CEO and co-founder when the company launches REVEAL Version 1.1 in 2012, a cloud-based clinical NLP service that turns unstructured narratives into structured, coded information for healthcare applications.

  3. 2023

    AI for migraine records

    A 2023 study he coauthors applies artificial intelligence to unstructured EHR data to identify migraine and associated symptoms and conditions.

  4. 2025

    AI-based asthma study

    For asthma features, he coauthors a 2025 study comparing AI processing of unstructured EHR data with traditional structured-data methods; advanced methods reach a 94.7% F1 score.

  5. 2025

    Verantos applies AI to records

    At Verantos, he serves as CEO in 2025 while the company applies AI to complete patient records to generate high-validity evidence across therapeutic areas.

  6. As of October 2026

    CEO, professor and HITAC member

    As of October 2026, he is Verantos' founder and CEO and a Clinical Professor of Surgery at Stanford University. He serves on HITAC through December 2026. Verantos' pharmacoepidemiology stack transforms fragmented real-world data into high-validity evidence, automates research workflows, and uses a scalable AI foundation.

Career

  1. NowHealth Information Technology Advisory CommitteeMember
  2. Since 2025VerantosCEO and Founder
  3. Since 2006Stanford UniversityClinical Professor of Surgery
  4. From 2012Health FidelityCEO and Co-founder
  5. 2006University of California, Los AngelesSurgical resident

Education

  1. Boston University
  2. Tufts University
  3. Massachusetts Institute of TechnologyMBA

Most-cited works

  1. Massive Transfusion Protocols: The Role of Aggressive Resuscitation Versus Product Ratio in Mortality Reduction2009 · Journal of the American College of Surgeons · 374 citations
  2. Innovation in Surgery2006 · Annals of Surgery · 226 citations
  3. Real world evidence in cardiovascular medicine: ensuring data validity in electronic health record-based studies2019 · Journal of the American Medical Informatics Association · 79 citations
  4. Machine Learning Approaches to Predict Asthma Exacerbations: A Narrative Review2023 · Advances in Therapy · 53 citations
  5. The ethics of innovation in pediatric surgery2006 · Seminars in Pediatric Surgery · 31 citations

Sources and credits

Photo: We have no published photo of Dan Riskin yet. Send us a free-licensed photo.

  1. Daniel Riskin | Innovators Under 35 innovatorsunder35.com. Checked 19 October 2026.
  2. Health Fidelity REVEAL Version 1.1 Extracts Unstructured Clinical Data prnewswire.com. Checked 19 October 2026.
  3. Using artificial intelligence to identify patients with migraine and associated symptoms and conditions within electronic health records pmc.ncbi.nlm.nih.gov. Checked 19 October 2026.
  4. Advanced Approaches to Generating High-validity Real-world Evidence in Asthma pmc.ncbi.nlm.nih.gov. Checked 19 October 2026.
  5. Verantos Ranked Number 444th Fastest-Growing Company in North America on the 2025 Deloitte Technology Fast 500™ verantos.com. Checked 19 October 2026.
  6. About Verantos: our story and leadership | Verantos verantos.ai. Checked 19 October 2026.
  7. Dan Riskin | Stanford Medicine med.stanford.edu. Checked 19 October 2026.
  8. ONC HITAC Member Profile: Dan Riskin healthit.gov. Checked 19 October 2026.
  9. HITAC Membership healthit.gov. Checked 19 October 2026.